Yuhan Corporation (000105.KS)
KRW 101900.0
(-3.04%)
KRW 101900.0
(-3.04%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 284.75 Billion KRW | 3.47% |
| 2022 | 275.21 Billion KRW | 0.16% |
| 2021 | 274.78 Billion KRW | 9.05% |
| 2020 | 251.98 Billion KRW | 34.82% |
| 2019 | 186.9 Billion KRW | -24.89% |
| 2018 | 248.86 Billion KRW | -8.23% |
| 2017 | 271.18 Billion KRW | -12.7% |
| 2016 | 310.64 Billion KRW | 28.18% |
| 2015 | 242.34 Billion KRW | 40.65% |
| 2014 | 172.3 Billion KRW | 21.82% |
| 2013 | 141.44 Billion KRW | 5.87% |
| 2012 | 133.6 Billion KRW | 16.94% |
| 2011 | 114.25 Billion KRW | 10.7% |
| 2010 | 103.2 Billion KRW | 1.08% |
| 2009 | 102.1 Billion KRW | 13.93% |
| 2008 | 89.61 Billion KRW | 24.78% |
| 2007 | 71.81 Billion KRW | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 305.35 Billion KRW | 1.41% |
| 2024 Q1 | 301.1 Billion KRW | 0.0% |
| 2023 Q4 | - KRW | -100.0% |
| 2023 Q2 | 263.9 Billion KRW | -4.63% |
| 2023 Q1 | 276.71 Billion KRW | 0.54% |
| 2023 FY | 284.75 Billion KRW | 3.47% |
| 2023 Q3 | 279.42 Billion KRW | 5.88% |
| 2022 Q4 | 275.21 Billion KRW | 0.08% |
| 2022 Q2 | 279.52 Billion KRW | -0.73% |
| 2022 Q3 | 274.99 Billion KRW | -1.62% |
| 2022 Q1 | 281.58 Billion KRW | 2.48% |
| 2022 FY | 275.21 Billion KRW | 0.16% |
| 2021 Q3 | 260.01 Billion KRW | -4.76% |
| 2021 FY | 274.78 Billion KRW | 9.05% |
| 2021 Q1 | 270.09 Billion KRW | 7.19% |
| 2021 Q4 | 274.78 Billion KRW | 5.68% |
| 2021 Q2 | 272.99 Billion KRW | 1.08% |
| 2020 Q3 | 251.84 Billion KRW | -0.9% |
| 2020 Q1 | 227.85 Billion KRW | 21.91% |
| 2020 Q2 | 254.12 Billion KRW | 11.53% |
| 2020 Q4 | 251.98 Billion KRW | 0.05% |
| 2020 FY | 251.98 Billion KRW | 34.82% |
| 2019 Q3 | 223.34 Billion KRW | -12.09% |
| 2019 Q1 | 254.29 Billion KRW | 2.18% |
| 2019 Q4 | 186.9 Billion KRW | -16.31% |
| 2019 FY | 186.9 Billion KRW | -24.89% |
| 2019 Q2 | 254.06 Billion KRW | -0.09% |
| 2018 Q3 | 298.18 Billion KRW | -2.82% |
| 2018 FY | 248.86 Billion KRW | -8.23% |
| 2018 Q1 | 333.11 Billion KRW | 22.84% |
| 2018 Q2 | 306.85 Billion KRW | -7.88% |
| 2018 Q4 | 248.86 Billion KRW | -16.54% |
| 2017 Q4 | 271.18 Billion KRW | -13.87% |
| 2017 FY | 271.18 Billion KRW | -12.7% |
| 2017 Q1 | 306.6 Billion KRW | -1.3% |
| 2017 Q2 | 303.73 Billion KRW | -0.93% |
| 2017 Q3 | 314.84 Billion KRW | 3.66% |
| 2016 FY | 310.64 Billion KRW | 28.18% |
| 2016 Q4 | 310.64 Billion KRW | 10.34% |
| 2016 Q3 | 281.54 Billion KRW | 1.71% |
| 2016 Q2 | 276.8 Billion KRW | 3.53% |
| 2016 Q1 | 267.35 Billion KRW | 10.32% |
| 2015 Q3 | 209.01 Billion KRW | -1.26% |
| 2015 Q2 | 211.68 Billion KRW | 5.61% |
| 2015 FY | 242.34 Billion KRW | 40.65% |
| 2015 Q1 | 200.43 Billion KRW | 16.32% |
| 2015 Q4 | 242.34 Billion KRW | 15.95% |
| 2014 Q3 | 157.23 Billion KRW | 5.13% |
| 2014 FY | 172.3 Billion KRW | 21.82% |
| 2014 Q1 | 147.12 Billion KRW | 4.02% |
| 2014 Q2 | 149.56 Billion KRW | 1.66% |
| 2014 Q4 | 172.3 Billion KRW | 9.58% |
| 2013 Q4 | 141.44 Billion KRW | -10.11% |
| 2013 Q1 | 121.5 Billion KRW | -9.06% |
| 2013 FY | 141.44 Billion KRW | 5.87% |
| 2013 Q2 | 128.54 Billion KRW | 5.8% |
| 2013 Q3 | 157.35 Billion KRW | 22.41% |
| 2012 Q1 | 86.03 Billion KRW | 0.0% |
| 2012 FY | 133.6 Billion KRW | 16.94% |
| 2012 Q4 | 133.6 Billion KRW | 0.0% |
| 2012 Q3 | - KRW | 0.0% |
| 2012 Q2 | - KRW | -100.0% |
| 2011 Q1 | 79.84 Billion KRW | 0.0% |
| 2011 Q2 | 80.36 Billion KRW | 0.65% |
| 2011 FY | 114.25 Billion KRW | 10.7% |
| 2011 Q3 | 75.89 Billion KRW | -5.56% |
| 2010 Q4 | - KRW | -100.0% |
| 2010 Q1 | 80.06 Billion KRW | 0.0% |
| 2010 Q2 | 76.94 Billion KRW | -3.91% |
| 2010 FY | 103.2 Billion KRW | 1.08% |
| 2010 Q3 | 80.37 Billion KRW | 4.47% |
| 2009 Q2 | 71.12 Billion KRW | 3.37% |
| 2009 Q1 | 68.8 Billion KRW | 0.0% |
| 2009 FY | 102.1 Billion KRW | 13.93% |
| 2009 Q4 | - KRW | -100.0% |
| 2009 Q3 | 72.95 Billion KRW | 2.58% |
| 2008 Q1 | 57.2 Billion KRW | 0.0% |
| 2008 Q3 | 66.21 Billion KRW | 5.12% |
| 2008 FY | 89.61 Billion KRW | 24.78% |
| 2008 Q4 | - KRW | -100.0% |
| 2008 Q2 | 62.99 Billion KRW | 10.12% |
| 2007 Q3 | 52.55 Billion KRW | 8.73% |
| 2007 Q1 | 54.2 Billion KRW | 0.0% |
| 2007 Q2 | 48.33 Billion KRW | -10.83% |
| 2007 FY | 71.81 Billion KRW | 0.0% |
| 2007 Q4 | - KRW | -100.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -544.949% |
| Dong-A Socio Holdings Co., Ltd. | 117.85 Billion KRW | -141.623% |
| Ildong Holdings Co., Ltd. | 91.16 Billion KRW | -212.351% |
| HANDOK Inc. | 94.46 Billion KRW | -201.445% |
| Kukje Pharma Co., Ltd. | 21.24 Billion KRW | -1240.477% |
| Dong-A ST Co., Ltd. | 116.31 Billion KRW | -144.82% |
| SAMSUNG PHARM. Co., LTD. | 16.25 Billion KRW | -1651.427% |
| Hanmi Pharm. Co., Ltd. | 288.81 Billion KRW | 1.404% |
| Hanall Biopharma Co.,Ltd | 32.38 Billion KRW | -779.315% |
| Ilyang Pharmaceutical Co.,Ltd | 61.72 Billion KRW | -361.337% |
| Dong Sung Bio Pharm.Co.,Ltd. | 19.47 Billion KRW | -1362.022% |
| MYUNGMOON Pharm co.,Ltd | 30.28 Billion KRW | -840.411% |
| Hana Pharm Co., Ltd. | 48.34 Billion KRW | -488.986% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -544.949% |
| Ilsung Pharmaceuticals Co., Ltd. | 31.24 Billion KRW | -811.498% |
| REYON Pharmaceutical Co., Ltd. | 35.17 Billion KRW | -709.517% |
| Aprogen pharmaceuticals,Inc. | 48.12 Billion KRW | -491.668% |
| JW Holdings Corporation | 147.58 Billion KRW | -92.94% |
| Ildong Pharmaceutical Co., Ltd. | 84.62 Billion KRW | -236.501% |
| Chong Kun Dang Pharmaceutical Corp. | 261.43 Billion KRW | -8.923% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | -168.409% |
| Shin Poong Pharm.Co.,Ltd. | 53.92 Billion KRW | -428.082% |
| Hyundai Pharmaceutical Co., Ltd. | 26.99 Billion KRW | -954.741% |
| Samil Pharmaceutical Co.,Ltd | 32.51 Billion KRW | -775.874% |
| Jeil Pharmaceutical Co.,Ltd | 109.76 Billion KRW | -159.419% |
| Yuyu Pharma, Inc. | 44.15 Billion KRW | -544.949% |
| Kwang Dong Pharmaceutical Co., Ltd. | 188.64 Billion KRW | -50.951% |
| Daewoong pharmaceutical Co.,Ltd | 241.54 Billion KRW | -17.89% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | -168.409% |
| Yuhan Corporation | 284.75 Billion KRW | 0.0% |
| Jeil Pharma Holdings Inc | 125.28 Billion KRW | -127.298% |
| Yungjin Pharm. Co., Ltd. | 61.98 Billion KRW | -359.388% |
| Suheung Co., Ltd. | 259.84 Billion KRW | -9.589% |
| JW Pharmaceutical Corporation | 106.09 Billion KRW | -168.409% |
| Samjin Pharmaceuticals Co., Ltd. | 79.6 Billion KRW | -257.725% |
| Korea United Pharm Inc. | 49.14 Billion KRW | -479.461% |
| CKD Bio Corp. | 69.08 Billion KRW | -312.203% |
| Daewon Pharmaceutical Co., Ltd. | 105.07 Billion KRW | -170.998% |
| Dongwha Pharm.Co.,Ltd | 70.69 Billion KRW | -302.787% |
| Whan In Pharm Co.,Ltd. | 54.05 Billion KRW | -426.766% |
| Shin Poong Pharm.Co.,Ltd. | 53.92 Billion KRW | -428.082% |
| Chong Kun Dang Holdings Corp. | 194.76 Billion KRW | -46.206% |
| Boryung Corporation | 189.8 Billion KRW | -50.026% |
| Bukwang Pharmaceutical Co., Ltd. | 56.83 Billion KRW | -401.055% |
| Ilyang Pharmaceutical Co.,Ltd | 61.72 Billion KRW | -361.337% |
| JW Lifescience Corporation | 23.39 Billion KRW | -1116.991% |